July 9, 2018 / 1:05 PM / 2 months ago

BRIEF-Mylan Adds To Central Nervous System Portfolio With Launch Of Generic Exelon® Patch

July 9 (Reuters) - Mylan NV:

* MYLAN ADDS TO CENTRAL NERVOUS SYSTEM PORTFOLIO WITH LAUNCH OF GENERIC EXELON® PATCH

* MYLAN- U.S. LAUNCH OF RIVASTIGMINE TRANSDERMAL SYSTEM, 4.6 MG/24 HRS, 9.5 MG/24 HRS AND 13.3 MG/24 HRS, A GENERIC VERSION OF NOVARTIS’ EXELON PATCH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below